These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1331472)

  • 1. Effects of the protein phosphatase inhibitors okadaic acid and calyculin A on metabolically inhibited and ischaemic isolated myocytes.
    Armstrong SC; Ganote CE
    J Mol Cell Cardiol; 1992 Aug; 24(8):869-84. PubMed ID: 1331472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein phosphatase inhibitors calyculin A and fostriecin protect rabbit cardiomyocytes in late ischemia.
    Armstrong SC; Gao W; Lane JR; Ganote CE
    J Mol Cell Cardiol; 1998 Jan; 30(1):61-73. PubMed ID: 9500865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcolemmal blebs and osmotic fragility as correlates of irreversible ischemic injury in preconditioned isolated rabbit cardiomyocytes.
    Armstrong SC; Shivell LC; Ganote CE
    J Mol Cell Cardiol; 2001 Jan; 33(1):149-60. PubMed ID: 11133231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the phospholipase inhibitor mepacrine on injury in ischemic and metabolically inhibited adult isolated myocytes.
    Armstrong SC; Ganote CE
    Am J Pathol; 1991 Mar; 138(3):545-55. PubMed ID: 2000934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 2,3-butanedione monoxime (BDM) on contracture and injury of isolated rat myocytes following metabolic inhibition and ischemia.
    Armstrong SC; Ganote CE
    J Mol Cell Cardiol; 1991 Sep; 23(9):1001-14. PubMed ID: 1942093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irreversible injury of isolated adult rat myocytes. Osmotic fragility during metabolic inhibition.
    Ganote CE; Vander Heide RS
    Am J Pathol; 1988 Aug; 132(2):212-22. PubMed ID: 3400772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposite effects of phosphatase inhibitors on L-type calcium and delayed rectifier currents in frog cardiac myocytes.
    Frace AM; Hartzell HC
    J Physiol; 1993 Dec; 472():305-26. PubMed ID: 8145146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calyculin A and okadaic acid: inhibitors of protein phosphatase activity.
    Ishihara H; Martin BL; Brautigan DL; Karaki H; Ozaki H; Kato Y; Fusetani N; Watabe S; Hashimoto K; Uemura D
    Biochem Biophys Res Commun; 1989 Mar; 159(3):871-7. PubMed ID: 2539153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasting effects of calyculin A and okadaic acid on the respiratory burst of human neutrophils.
    Djerdjouri B; Combadière C; Pedruzzi E; Hakim J; Périanin A
    Eur J Pharmacol; 1995 Jan; 288(2):193-200. PubMed ID: 7720781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of okadaic acid and calyculin A on thrombin induced platelet reaction.
    Murata K; Sakon M; Kambayashi J; Yukawa M; Ariyoshi H; Shiba E; Kawasaki T; Kang J; Mori T
    Biochem Int; 1992 Feb; 26(2):327-34. PubMed ID: 1313673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of osmotic stress on sarcolemmal integrity of isolated cardiomyocytes following transient metabolic inhibition.
    Ruiz-Meana M; García-Dorado D; González MA; Barrabés JA; Soler-Soler J
    Cardiovasc Res; 1995 Jul; 30(1):64-9. PubMed ID: 7553725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of calcium depletion and loading on injury during metabolic inhibition of isolated adult rat myocytes.
    Rim DS; Altschuld RA; Ganote CE
    J Mol Cell Cardiol; 1990 Feb; 22(2):227-37. PubMed ID: 2109081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein phosphatase inhibitors and bone resorption: inhibition by okadaic acid and biphasic actions of calyculin-A.
    Goad DL; Meurer EA; Voelkel EF; Petrou CP; Tashjian AH
    Endocrinology; 1992 Jun; 130(6):3402-10. PubMed ID: 1375901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug-resistant human KB carcinoma cells are highly resistant to the protein phosphatase inhibitors okadaic acid and calyculin A. Analysis of potential mechanisms involved in toxin resistance.
    Chambers TC; Raynor RL; Kuo JF
    Int J Cancer; 1993 Jan; 53(2):323-7. PubMed ID: 8093882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Okadaic acid-induced decrease in the magnitude and efficacy of the Ca2+ signal in pancreatic beta cells and inhibition of insulin secretion.
    Sato Y; Mariot P; Detimary P; Gilon P; Henquin JC
    Br J Pharmacol; 1998 Jan; 123(1):97-105. PubMed ID: 9484859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preconditioning of isolated rabbit cardiomyocytes: effects of glycolytic blockade, phorbol esters, and ischaemia.
    Armstrong S; Ganote CE
    Cardiovasc Res; 1994 Nov; 28(11):1700-6. PubMed ID: 7842465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell apoptosis induced by interleukin-2 deprivation or transforming growth factor-beta 2: modulation by the phosphatase inhibitors okadaic acid and calyculin A.
    Weller M; Malipiero U; Groscurth P; Fontana A
    Exp Cell Res; 1995 Dec; 221(2):395-403. PubMed ID: 7493639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of protein phosphatase type 1 and 2A attenuate phosphatidylinositol metabolism and Ca(2+)-transients in human platelets. Role of a cdc2-related protein kinase.
    Lerea KM
    Biochemistry; 1992 Jul; 31(28):6553-61. PubMed ID: 1321663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential inhibitory effects of serine/threonine phosphatase inhibitors and a calmodulin antagonist on phosphoinositol/calcium- and cyclic adenosine monophosphate-mediated pancreatic amylase secretion.
    Meyer-Alber A; Höcker M; Fetz I; Fornefeld H; Waschulewski IH; Fölsch UR; Schmidt WE
    Scand J Gastroenterol; 1995 Apr; 30(4):384-91. PubMed ID: 7541915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and electrophysiological mechanisms of the positive inotropic effect of calyculin A, a protein phosphatase inhibitor.
    Neumann J; Bokník P; Herzig S; Schmitz W; Scholz H; Wiechen K; Zimmermann N
    J Pharmacol Exp Ther; 1994 Oct; 271(1):535-41. PubMed ID: 7965753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.